General Range
NORMPARA-P
Price on request/100 · MOQ 100 boxes
Normpara-P Suspension by Enormmed Pharma Private Limited is a paediatric formulation containing Paracetamol, commonly used for reducing fever and providing relief from mild to moderate pain in children.
Paracetamol is an analgesic and antipyretic medicine that works primarily within the central nervous system to reduce pain perception and help regulate elevated body temperature. It is commonly recommended for fever, headaches, toothaches, body aches and discomfort associated with common childhood illnesses.
Normpara-P Suspension may also be recommended for managing fever and discomfort following childhood vaccinations when medically appropriate. Its oral suspension formulation allows administration of a measured liquid dose based on the child's age, body weight and the product's concentration.
Available in a 60 ml bottle, Normpara-P Suspension is intended for paediatric use. Parents and caregivers should follow a paediatrician's instructions and use an appropriate oral measuring device to ensure accurate dosing.
CategoryGeneral Range
Min. Order100 boxes
Supplied byEnorm Med Pharma Pvt. Ltd.
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Paracetamol Oral Suspension IP
- Packaging Type
- Oral Suspension / Syrup
- Packaging Size
- 60 ml
- Dosage Form
- syrup
- Treatment
- Fever Reduction: Helps lower elevated body temperature in children.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Enorm Med Pharma Pvt. Ltd.Panchkula, Haryana
Enorm Med Pharma Private Limited is an Indian pharmaceutical company based in Panchkula, Haryana, specializing in the manufacture, trade, wholesale, and export of a wide range of pharmaceutical formulations.
Company Overview
• Incorporation / Establishment: Originally started as a proprietorship in 2021, later incorporated as a private limited company on April 9, 2023 (CIN: U46497HR2023PTC110540).
• Registered Address: SCO 272, Sector-20, Panchkula, Haryana – 134116, India.
• Directors / Leadership: Sukhinder Jindal and Gurpreet Jindal.
• Certifications: ISO 9001:2015 and WHO-GMP compliant operations/standards.
• Business Model: PCD (Propaganda Cum Distribution) Pharma Franchise, third-party manufacturing, wholesale distribution, and domestic/global supply.
Product Portfolio
Enorm Med Pharma deals in diverse therapeutic segments and dosage forms, including:
• Dosage Forms: Tablets, capsules, softgelatin capsules, syrups, dry syrups, injections (vials), and ointments.
• Therapeutic Ranges: Anti-infectives, cardiac, diabetic, dermatology, and general wellness/herbal formulas.
• Notable Branded Products: Azeenorm (Azithromycin), Diclonorm, Enomzole-D, Levonorm, Pantenorm, Norsunate (Artesunate injections), and Mebenorm.
More General Range
